Longitudinal sampling sheds light on SARS-CoV-2 fecal shedding dynamics

Michael P Coryell; Paul E Carlson Jr

doi:10.1016/j.medj.2022.05.015

Longitudinal sampling sheds light on SARS-CoV-2 fecal shedding dynamics

Med. 2022 Jun 10;3(6):351-352. doi: 10.1016/j.medj.2022.05.015.

Authors

Michael P Coryell¹, Paul E Carlson Jr²

Affiliations

¹ Laboratory of Mucosal Pathogens and Cellular Immunology, Division of Bacterial, Parasitic, and Allergenic Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
² Laboratory of Mucosal Pathogens and Cellular Immunology, Division of Bacterial, Parasitic, and Allergenic Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: paul.carlson@fda.hhs.gov.

Abstract

Persistent fecal shedding of SARS-CoV-2 viral RNA has remained a clinical feature of interest throughout the COVID-19 pandemic. In this issue of Med, Natarajan et al. report fecal shedding dynamics of individuals diagnosed with mild-to-moderate COVID-19 disease and sampled longitudinally for up to 10 months¹.

Published by Elsevier Inc.

Publication types

Research Support, U.S. Gov't, P.H.S.
Comment

MeSH terms

COVID-19*
Humans
Pandemics
RNA, Viral / genetics
SARS-CoV-2* / genetics
Virus Shedding

Substances

RNA, Viral